Int. J. Environ. Res. Public Health 2011, 8 Limitations 2514 The main limitation of this study is the reliance on self-reported medication use and CVD conditions data. Participant differences in recall or reporting of medication use, health conditions, and hospitalization could influence the risk model. Acknowledgements This research from the Jackson Heart Study is supported by NIH contracts N01-HC-95170, N01-HC-95171, and N01-HC-95172 provided by the National Heart, Lung, and Blood Institute and the National Center for Minority Health and Health Disparities. References 1. Rosamond, W.; Flegal, K.; Friday, G.; Furie, K.; Greenlund, K.; Haase, N.; Ho, M. Heart disease and stroke statistics—2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115, 69-171. 2. Elsayed, E.F.; Tighiouart, H.; Griffith, J.; Kurth, T.; Levey, A.S.; Salem, D.; Sarnak, M.J.; Weiner, D.E. Cardiovascular disease and subsequent kidney disease. Arch. Intern. Med. 2007, 167, 1130- 1136. 3. Munger, M.A.; Van Tassell, B.W.; LaFleur, J. Medication nonadherence: An unrecognized cardiovascular risk factor. Medsc. Gen. Med. 2007, 9, 58. 4. LaFleur, J.; Oderda, G.M. Methods to measure patient compliance with medication regimens. J. Pain Palliat. Care Pharmacother. 2004, 18, 81-87. 5. Osterberg, L.; Blaschke, T. Adherence to medication. NEJM 2005, 353, 487-497. 6. Rasmussen, J.N.; Chong, A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007, 297, 177-186. 7. Ho, P.M.; Rumsfeld, J.S.; Masoudi, F.A.; McClure, D.L.; Plomondon, M.E.; Steiner, J.F.; Magid, D.J. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch. Intern. Med. 2006, 166, 1836-1841. 8. Sajatovic, M.; Bauer, M.S.; Kilbourne, A.M.; Vertrees, J.E.; Williford, W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr. Serv. 2006, 57, 56-62. 9. Chisholm, M.A.; Williamson, G.M.; Lance, C.E.; Mulloy, L.E. Predicting adherence to immunosuppressant therapy: A prospective analysis of the theory of planned behavior. Nephrol. Dial. Transplant. 2007, 22, 2339-2348. 10. Senst, B.L.; Achusim, L.E.; Genest, R.P.; Consentino, L.A.; Ford, C.C.; Little, J.A.; Raybon, S.J.; Bates, D.W. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am. J. Health Syst. Pharm. 2002, 58, 1126-1132. 11. O’ Conner, P. Improving medication adherence. Arch. Intern. Med. 2006, 166, 1802-1804. 12. Pladevall, M.; Williams, L.K.; Potts, L.A.; Divine, G.; Xi, H.; Lafata, J.E. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004, 27, 2800-2805.